It was found to be overexpressed in the vasculature of various solid tumors [37], as well as in two subtypes of precursor B-ALL in samples with high expression of binder of MAP3K1 and KLF4 (BAALC) [38]. This evidence concerns the gene MAP3K1 and acute lymphoblastic leukemia.